A question kit for finding care
Bring a question. Expect a clear answer.
Ask for the reason behind each test and a clear plan for discussing the result.
Federal requirements as of September 26, 2026, do not impose blood tests across all prescriptions.
That does not settle which tests an assessment needs; state rules, the care standard, and some drug-specific programs can add requirements.
A question to take with you
What question does this test answer, and how would its result change the plan?
Ask for the purpose in ordinary words. Find out who would talk you through the result, and whether the quoted fee includes that conversation.
The reviewed sermorelin studies tracked growth hormone response, blood sugar, blood fats, and IGF-1, a growth factor linked to growth hormone.
A growth factor is a body signal involved in growth.
With no current Food and Drug Administration (FDA) label as of September 28, 2026, sermorelin has no label-based checklist for testing.
Those study measurements describe research, not a set of tests that every prescriber must order.
Evidence to keep in view
Research measurements do not by themselves establish what a particular person needs before or during care.
The clinician needs to explain the reason for the proposed tests rather than present a research list as a universal rule.
Write the answers together. A number changing on a test and a change you notice in daily life may be different goals.
If the plan is still vague, ask for the next decision to be made explicit. What information is missing, and who is responsible for getting it?
Put the uncertainty beside the hoped-for benefit.
Talk through possible harms →